BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32165146)

  • 1. Effect of Ginsenoside-Rh2 and Curcurbitacin-B on Cryptosporidium parvum in vitro.
    Shahiduzzaman M; Ras R; Widmer G
    Exp Parasitol; 2020 May; 212():107873. PubMed ID: 32165146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paromomycin and geneticin inhibit intracellular Cryptosporidium parvum without trafficking through the host cell cytoplasm: implications for drug delivery.
    Griffiths JK; Balakrishnan R; Widmer G; Tzipori S
    Infect Immun; 1998 Aug; 66(8):3874-83. PubMed ID: 9673275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of cell culture and quantitative PCR for screening of drugs against Cryptosporidium parvum.
    Shahiduzzaman M; Dyachenko V; Obwaller A; Unglaube S; Daugschies A
    Vet Parasitol; 2009 Jun; 162(3-4):271-7. PubMed ID: 19342176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a microtitre ELISA to quantify development of Cryptosporidium parvum in vitro.
    Woods KM; Nesterenko MV; Upton SJ
    FEMS Microbiol Lett; 1995 Apr; 128(1):89-94. PubMed ID: 7744242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry based assay to determine the effects of treatments on Cryptosporidium parvum viability.
    Phelps KK; Lindsay DS; Sumner SS; Fayer R
    J Eukaryot Microbiol; 2001; Suppl():40S-41S. PubMed ID: 11906073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic anticryptosporidial potential of the combination alpha-1-antitrypsin and paromomycin.
    Forney JR; Yang S; Healey MC
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2006-8. PubMed ID: 9303402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro determination of anticryptosporidial activity of phytogenic extracts and compounds.
    Teichmann K; Kuliberda M; Schatzmayr G; Hadacek F; Joachim A
    Parasitol Res; 2012 Jul; 111(1):231-40. PubMed ID: 22278729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonistic effect of human alpha-1-antitrypsin on excystation of Cryptosporidium parvum oocysts.
    Forney JR; Yang S; Healey MC
    J Parasitol; 1997 Aug; 83(4):771-4. PubMed ID: 9267429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin analogs inhibit in vitro growth of Cryptosporidium parvum.
    Perkins ME; Wu TW; Le Blancq SM
    Antimicrob Agents Chemother; 1998 Apr; 42(4):843-8. PubMed ID: 9559794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum.
    Hommer V; Eichholz J; Petry F
    J Antimicrob Chemother; 2003 Sep; 52(3):359-64. PubMed ID: 12888587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of 101 antimicrobials and other agents on the development of Cryptosporidium parvum in vitro.
    Woods KM; Nesterenko MV; Upton SJ
    Ann Trop Med Parasitol; 1996 Dec; 90(6):603-15. PubMed ID: 9039272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunofluorescence detection of Cryptosporidium parvum in Caco-2 cells: a new screening method for anticryptosporidial agents.
    Favennec L; Egraz-Bernard M; Comby E; Lemeteil D; Ballet JJ; Brasseur P
    J Eukaryot Microbiol; 1994; 41(5):39S. PubMed ID: 7804239
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro cultivation of Cryptosporidium parvum and screening for anticryptosporidial drugs.
    McDonald V; Stables R; Warhurst DC; Barer MR; Blewett DA; Chapman HD; Connolly GM; Chiodini PL; McAdam KP
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1498-500. PubMed ID: 2221857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic studies on protopanaxadiol, Rh2, and ginseng (Panax quinquefolius) extract induced cytotoxicity in intestinal Caco-2 cells.
    Popovich DG; Kitts DD
    J Biochem Mol Toxicol; 2004; 18(3):143-9. PubMed ID: 15252870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-protozoal activity of extracts from chicory (Cichorium intybus) against Cryptosporidium parvum in cell culture.
    Woolsey ID; Valente AH; Williams AR; Thamsborg SM; Simonsen HT; Enemark HL
    Sci Rep; 2019 Dec; 9(1):20414. PubMed ID: 31892721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme immunoassay detection of Cryptosporidium parvum inhibition by sinefungin in sporozoite infected HCT-8 enterocytic cells.
    Gargala G; Delaunay A; Favennec L; Brasseur P; Ballet JJ
    Int J Parasitol; 1999 May; 29(5):703-9. PubMed ID: 10404264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro model of infection of human biliary epithelial cells by Cryptosporidium parvum.
    Verdon R; Keusch GT; Tzipori S; Grubman SA; Jefferson DM; Ward HD
    J Infect Dis; 1997 May; 175(5):1268-72. PubMed ID: 9129102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with agmatine inhibits Cryptosporidium parvum infection in infant mice.
    Moore D; Waters WR; Wannemuehler MJ; Harp JA
    J Parasitol; 2001 Feb; 87(1):211-3. PubMed ID: 11227893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the effects of two dinitroanilines against Cryptosporidium parvum in vitro and in vivo in neonatal mice and rats.
    Armson A; Sargent K; MacDonald LM; Finn MP; Thompson RC; Reynoldson JA
    FEMS Immunol Med Microbiol; 1999 Nov; 26(2):109-13. PubMed ID: 10536296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.